FPMAJ Demands Better Criteria for Selecting Comparator Drugs to Factor in Disease Features and Product Positioning

The Federation of Pharmaceutical Manufacturers’ Associations of Japan’s (FPMAJ) drug pricing committee spoke of the challenges in the current pricing mechanism of innovative drugs and proposed countermeasures at a press conference on June 9. The trade group pointed out that...read more